Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)

https://www.globenewswire.com/news-release/2022/09/30/2525830/0/en/Zealand-Pharma-Announces-Positive-Results-from-Phase-3-Trial-of-Glepaglutide-in-Patients-with-Short-Bowel-Syndrome-EASE-1.html

company announcement